Leukemia Research Foundation Inc
- Assets
- $4.5m
- Revenue
- $2.6m
- Investments
- $0.0
- Employees
- 7
- Location
- Northfield, IL
- Founding
- 11/1954
- Data as of
- 06/2021
- EIN
- 36-6102182
Organization Overview
Leukemia Research Foundation Inc is located in Northfield, IL. The organization was established in 1954. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. As of 06/2021, Leukemia Research Foundation Inc employed 7 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations.
For the year ending 06/2021, Leukemia Research Foundation Inc generated $2.6m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 5.0% each year. All expenses for the organization totaled $2.5m during the year ending 06/2021. While expenses have increased by 3.8% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2018, Leukemia Research Foundation Inc has awarded 37 individual grants totaling $4,187,468. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE LEUKEMIA RESEARCH FOUNDATION IS DEDICATED TO CONQUERING ALL BLOOD CANCERS BY FUNDING RESEARCH INTO THEIR CAUSES AND CURES, AND ENRICHING THE QUALITY OF LIFE OF THOSE TOUCHED BY THESE DISEASES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
WE FUND PROMISING RESEARCH WORLDWIDE TO ACCELERATE THE DEVELOPMENT OF NEW TREATMENTS AND THERAPIES FOR ALL BLOOD CANCERS, INCLUDING LEUKEMIA, LYMPHOMA, MYELOMA, AND MYELODYSPLASTIC SYNDROMES. OUR RESEARCHERS' PROJECTS IN GENOMICS, IMMUNOTHERAPIES, AND STEM CELL BIOLOGY HAVE ADVANCED OUR UNDERSTANDING OF WHAT DRIVES THESE CANCERS TO FORM AND PROGRESS AND WHAT BIOLOGICAL MARKERS COULD BE TARGETS FOR TREATMENT. IN FISCAL YEAR 2021, WE AWARDED FOURTEEN $100,000 GRANTS TO RESEARCHERS WORLDWIDE.
OUR NEED-BASED PATIENT GRANT PROGRAM IS INTENDED TO ASSIST PATIENTS AND THEIR FAMILIES BY EASING THE FINANCIAL BURDEN SO THEY CAN FOCUS ON THEIR HEALTH AND TREATMENT. ELIGIBLE PATIENTS WITH LEUKEMIA, LYMPHOMA, MYELOMA, OR MYELODYSPLASTIC SYNDROME CAN RECEIVE A ONE-TIME GRANT OF UP TO $1,500. IN FISCAL YEAR 2021, WE DISPERSED GRANTS TO 100 PATIENTS.
THROUGH OUR FREE EDUCATION CONFERENCES AND WEBINARS, PATIENTS AND THEIR LOVED ONES CAN LEARN ABOUT VARIOUS BLOOD CANCER-RELATED TOPICS AND SPEAK WITH EXPERT HEMATOLOGY/ONCOLOGY PHYSICIANS. IN FISCAL YEAR 2021, APPROXIMATELY 836 PEOPLE REGISTERED FOR OUR EDUCATION PROGRAMS.WE ALSO OFFER FREE PEER SUPPORT SERVICES TO BLOOD CANCER PATIENTS AND CAREGIVERS, INCLUDING AN ONLINE SUPPORT COMMUNITY, AND PARTNER WITH A CANCER SUPPORT ORGANIZATION TO PROVIDE A PEER MENTORING PROGRAM. IN FISCAL YEAR 2021, MORE THAN 4,000 PEOPLE PARTICIPATED IN OUR PEER SUPPORT PROGRAMS.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Kevin Radelet Executive Director | Officer | 37.5 | $130,289 |
Patty Mix Secretary | OfficerTrustee | 0.5 | $0 |
Blake Brandwein President | OfficerTrustee | 0.5 | $0 |
Gerald Brin Treasurer | OfficerTrustee | 0.5 | $0 |
Todd Holmes At Large Member | Trustee | 0.5 | $0 |
John Burke At Large Member | Trustee | 0.5 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $29,225 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $186,901 |
| All other contributions, gifts, grants, and similar amounts not included above | $2,358,416 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $2,574,542 |
| Total Program Service Revenue | $0 |
| Investment income | $14,482 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | -$30,707 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $2,562,072 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $1,300,000 |
| Grants and other assistance to domestic individuals. | $150,597 |
| Grants and other assistance to Foreign Orgs/Individuals | $100,000 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $146,394 |
| Compensation of current officers, directors, key employees. | $35,286 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $468,753 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $55,712 |
| Payroll taxes | $46,466 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $20,600 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $5,681 |
| Office expenses | $31,390 |
| Information technology | $25,177 |
| Royalties | $0 |
| Occupancy | $64,112 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $8,447 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $1,301 |
| Insurance | $6,474 |
| All other expenses | $0 |
| Total functional expenses | $2,472,196 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $511,666 |
| Savings and temporary cash investments | $423,765 |
| Pledges and grants receivable | $556,556 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $9,225 |
| Net Land, buildings, and equipment | $1,718 |
| Investments—publicly traded securities | $2,532,316 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $487,683 |
| Total assets | $4,522,929 |
| Accounts payable and accrued expenses | $24,341 |
| Grants payable | $1,424,281 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $1,448,622 |
| Net assets without donor restrictions | $2,505,927 |
| Net assets with donor restrictions | $568,380 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $4,522,929 |
Grants Awarded
Over the last fiscal year, Leukemia Research Foundation Inc has awarded $1,300,000 in support to 11 organizations.
| Grant Recipient | Amount |
|---|---|
La Jolla, CA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $200,000 |
Rochester, MN PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $200,000 |
Philadelphia, PA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Columbus, OH PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Baltimore, MD PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Philadelphia, PA PURPOSE: NEW INVESTIGATOR RESEARCH GRANT | $100,000 |
Grants Recieved
Over the last fiscal year, we have identified 20 grants that Leukemia Research Foundation Inc has recieved totaling $169,220.
| Awarding Organization | Amount |
|---|---|
William R Rich Foundation Rosemont, IL PURPOSE: SUPPORT | $75,000 |
Cole-Crone Family Foundation Inc Deerfield, IL PURPOSE: UNRESTRICTED | $50,000 |
American Online Giving Foundation Inc Newark, DE PURPOSE: GENERAL SUPPORT | $14,059 |
Network For Good Inc Washington, DC PURPOSE: Unrestricted | $13,931 |
John Dykema And Michele Maly-Dykema Family Foundation Spring Lake, MI PURPOSE: GENERAL SUPPORT | $5,000 |
Lichtenheld Family Foundation Woodstock, IL PURPOSE: CHARITABLE CONTRIBUTION | $5,000 |
Endowment Analysis
| Beg. Balance | $84,594 |
| Earnings | $1,220 |
| Other Expense | $454 |
| Ending Balance | $85,360 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Lungevity Foundation Chicago, IL | $5,616,354 | $11,431,213 |
Citizens United For Research In Epilepsy Chicago, IL | $10,595,195 | $7,343,836 |
Pkd Foundation Kansas City, MO | $20,909,832 | $16,124,449 |
Foundation For Angelman Syndrome Therapeutics Downers Grove, IL | $12,005,469 | $5,739,183 |
American Medical Association Foundation Chicago, IL | $25,501,646 | $2,567,190 |
Partnership For Cures Chicago, IL | $1,824,558 | $2,575,448 |
Omega Medical Grants Association Rosemont, IL | $2,309,415 | $2,417,581 |
Leukemia Research Foundation Inc Northfield, IL | $4,522,929 | $2,562,072 |
Head For The Cure Kansas City, MO | $578,705 | $2,327,981 |
Orthopaedic Foot & Ankle Foundation Rosemont, IL | $8,113,022 | $2,155,085 |
Levelup Kids Inc Kansas City, MO | $1,306,586 | $1,337,592 |
St Louis Life Sciences Project St Louis, MO | $739,815 | $595,897 |